DTR — Diagnostear Technologies Balance Sheet
0.000.00%
- CA$19.16m
- CA$18.01m
Annual balance sheet for Diagnostear Technologies, fiscal year end - December 31st, millions except per share.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | |
| Standards: | — | IFRS | IFRS | IFRS |
| Status: | fx Preliminary | Final | Final | Final |
| Cash | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | — | 0.275 | 2.48 | 1.34 |
| Total Other Current Assets | ||||
| Total Current Assets | — | 0.286 | 2.62 | 1.59 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | — | 1.52 | 1.48 | 1.68 |
| Long Term Investments | ||||
| Total Assets | — | 1.81 | 4.14 | 3.31 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | — | 0.329 | 0.292 | 0.279 |
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Minority Interest | ||||
| Total Other Liabilities | ||||
| Total Liabilities | — | 0.639 | 0.796 | 0.82 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | — | 1.17 | 3.35 | 2.49 |
| Total Liabilities & Shareholders' Equity | — | 1.81 | 4.14 | 3.31 |
| Total Common Shares Outstanding |